Kwality Pharmaceuticals receives SFDA GMP approval for 2 units

Kwality Pharmaceuticals Limited has successfully obtained SFDA GMP Approval for the 2 audited units.

Unit-1 – Amritsar – Generic Injectable facility (Sterile Products; Lyopholised Injectables, Small Volume Liquids, Dry powder for injection and terminally sterilized small volume liquids) and

Unit-2 – Amritsar – Beta- lactam (Sterile Products; Penicillins and Dry Powder Injectables).

SFDA is an esteemed regulatory agency which is now a PIC/s member state.

This certification will open new markets for the Kwality Pharma such as Saudi Arabia, UAE, Jordan, Bahrain, Kuwait, Oman and Qatar and the 50+ PIC/S countries as well through mutual reorganization.

As Saudi Arabia is considered as reference state for registrations across GCC markets, products under registration in the market can be registered across the cluster of 7+ GCC markets simultaneously.